Why the study?
Does cardiovascular magnetic resonance identifying specific phenotypic features predict the presence of sarcomere gene mutations in subclinical hypertrophic cardiomyopathy?
Does cardiovascular magnetic resonance identifying specific phenotypic features predict the presence of sarcomere gene mutations in subclinical hypertrophic cardiomyopathy?
Specific CMR findings, including crypts and anterior mitral valve leaflet elongation, can help identify sarcomere gene mutations in subclinical hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May inform genetic testing in subclinical HCM; leaves open prospective validation and outcome prediction.
The subclinical hypertrophic cardiomyopathy phenotype measured by cardiovascular magnetic resonance in a multicenter environment and consisting of crypts (particularly multiple), anterior mitral valve leaflet elongation, abnormal trabeculae, and smaller LV systolic cavity is indicative of the presence of sarcomere gene mutations and highlights the need for further study.
No takes yet. Share an insight, caveat, or question.
Captur et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: